These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 19357124)

  • 21. [Mutation of the activin receptor-like kinase 1(ALK1) gene and the expression of plasma thrombomodulin in type-2 hereditary hemorrhagic telangiectasia: a study of a Chinese family].
    Zhang GS; Peng HL; Yi Y; Xie DH; He XB
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):182-5. PubMed ID: 15059530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia.
    Pousada G; Baloira A; Valverde D
    Med Clin (Barc); 2015 Mar; 144(6):261-4. PubMed ID: 25543221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary pulmonary hypertension family with
    Lin YK; Yang DH; Lei C; Luo H
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jun; 46(6):558-564. PubMed ID: 37278169
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary arterial hypertension as the first manifestation in a patient with hereditary hemorrhagic telangiectasia.
    Ishiwata T; Terada J; Tanabe N; Abe M; Sugiura T; Tsushima K; Tada Y; Sakao S; Kasahara Y; Nakanishi N; Morisaki H; Tatsumi K
    Intern Med; 2014; 53(20):2359-63. PubMed ID: 25318803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
    Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
    J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
    Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A
    J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.
    Abdalla SA; Gallione CJ; Barst RJ; Horn EM; Knowles JA; Marchuk DA; Letarte M; Morse JH
    Eur Respir J; 2004 Mar; 23(3):373-7. PubMed ID: 15065824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary hypertension in hereditary haemorrhagic teleangiectasia].
    Reichenberger F; Wehner LE; Breithecker A; Voswinckel R; Mensch O; Schulz R; Ghofrani HA
    Pneumologie; 2009 Nov; 63(11):669-74. PubMed ID: 19790036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
    Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
    Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical features of patients with pulmonary artery hypertension associated with hereditary hemorrhagic telangiectasia].
    Lu JG; Sun ML; Lü B; Chen XB; Hou ZH; Jiang SL; Dai RP; Su X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):164-7. PubMed ID: 21426754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions.
    Peacock HM; Caolo V; Jones EA
    Cardiovasc Res; 2016 Feb; 109(2):196-203. PubMed ID: 26645978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia.
    Al-Saleh S; Mei-Zahav M; Faughnan ME; MacLusky IB; Carpenter S; Letarte M; Ratjen F
    Eur Respir J; 2009 Oct; 34(4):875-81. PubMed ID: 19386691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
    Seki T; Yun J; Oh SP
    Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
    Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH.
    Montani D; Price LC; Girerd B; Chinet T; Lacombe P; Simonneau G; Humbert M
    Eur Respir Rev; 2009 Mar; 18(111):42-6. PubMed ID: 20956122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and molecular genetic features of hereditary pulmonary arterial hypertension.
    Brenner L; Chung WK
    Compr Physiol; 2011 Oct; 1(4):1721-8. PubMed ID: 23733703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
    Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
    Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of multiple ACVRL1 mutations in patients with pulmonary arterial hypertension by targeted exome capture.
    Piao C; Zhu Y; Zhang C; Xi X; Liu X; Zheng S; Li X; Guo J; Jia L; Nakanishi T; Cai T; Gu H; Du J
    Clin Sci (Lond); 2016 Sep; 130(17):1559-69. PubMed ID: 27316748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.